MedCap AB Statistics

Total Valuation

MedCap AB has a market cap or net worth of SEK 6.41 billion. The enterprise value is 6.45 billion.

Market Cap	6.41B
Enterprise Value	6.45B

Important Dates

The next estimated earnings date is Wednesday, July 23, 2025.

Earnings Date	Jul 23, 2025
Ex-Dividend Date	n/a

Share Statistics

MedCap AB has 15.04 million shares outstanding. The number of shares has decreased by -0.11% in one year.

Current Share Class	15.04M
Shares Outstanding	15.04M
Shares Change (YoY)	-0.11%
Shares Change (QoQ)	+0.98%
Owned by Insiders (%)	3.87%
Owned by Institutions (%)	57.11%
Float	11.50M

Valuation Ratios

The trailing PE ratio is 31.35 and the forward PE ratio is 28.17.

PE Ratio	31.35
Forward PE	28.17
PS Ratio	3.48
PB Ratio	4.88
P/TBV Ratio	10.98
P/FCF Ratio	22.16
P/OCF Ratio	19.84
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.18, with an EV/FCF ratio of 22.29.

EV / Earnings	31.93
EV / Sales	3.51
EV / EBITDA	19.18
EV / EBIT	27.98
EV / FCF	22.29

Financial Position

The company has a current ratio of 2.67, with a Debt / Equity ratio of 0.26.

Current Ratio	2.67
Quick Ratio	1.83
Debt / Equity	0.26
Debt / EBITDA	1.03
Debt / FCF	1.20
Interest Coverage	12.26

Financial Efficiency

Return on equity (ROE) is 16.92% and return on invested capital (ROIC) is 9.47%.

Return on Equity (ROE)	16.92%
Return on Assets (ROA)	7.57%
Return on Invested Capital (ROIC)	9.47%
Return on Capital Employed (ROCE)	13.62%
Revenue Per Employee	3.23M
Profits Per Employee	354,211
Employee Count	592
Asset Turnover	0.97
Inventory Turnover	2.67

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -20.96% in the last 52 weeks. The beta is 0.52, so MedCap AB's price volatility has been lower than the market average.

Beta (5Y)	0.52
52-Week Price Change	-20.96%
50-Day Moving Average	402.00
200-Day Moving Average	471.99
Relative Strength Index (RSI)	47.97
Average Volume (20 Days)	21,848

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, MedCap AB had revenue of SEK 1.84 billion and earned 201.90 million in profits. Earnings per share was 13.59.

Revenue	1.84B
Gross Profit	1.08B
Operating Income	230.40M
Pretax Income	255.40M
Net Income	201.90M
EBITDA	298.60M
EBIT	230.40M
Earnings Per Share (EPS)	13.59

Full Income Statement

Balance Sheet

The company has 315.20 million in cash and 347.30 million in debt, giving a net cash position of -32.10 million or -2.13 per share.

Cash & Cash Equivalents	315.20M
Total Debt	347.30M
Net Cash	-32.10M
Net Cash Per Share	-2.13
Equity (Book Value)	1.31B
Book Value Per Share	87.20
Working Capital	570.60M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 323.00 million and capital expenditures -33.80 million, giving a free cash flow of 289.20 million.

Operating Cash Flow	323.00M
Capital Expenditures	-33.80M
Free Cash Flow	289.20M
FCF Per Share	19.22

Full Cash Flow Statement

Margins

Gross margin is 58.48%, with operating and profit margins of 12.53% and 10.98%.

Gross Margin	58.48%
Operating Margin	12.53%
Pretax Margin	13.88%
Profit Margin	10.98%
EBITDA Margin	16.23%
EBIT Margin	12.53%
FCF Margin	15.72%

Dividends & Yields

MedCap AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.11%
Shareholder Yield	n/a
Earnings Yield	3.15%
FCF Yield	4.51%

Stock Splits

The last stock split was on September 27, 2016. It was a reverse split with a ratio of 0.1.

Last Split Date	Sep 27, 2016
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a